Cargando…

Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™)

INTRODUCTION: Multiple sclerosis (MS) typically requires life-long management with disease-modifying therapies (DMTs). Many DMTs require regular self-injection, and can be associated with injection site reactions, pain, and needle/injection phobia—but these can be addressed by improvements in autoin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziemssen, Tjalf, Sylvester, Lauren, Rametta, Mark, Ross, Amy Perrin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685867/ https://www.ncbi.nlm.nih.gov/pubmed/26662362 http://dx.doi.org/10.1007/s40120-015-0036-y

Ejemplares similares

Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b
por: Weller, Ivonne, et al.
Publicado: (2015)

Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors
por: Barone, Donald A., et al.
Publicado: (2016)

Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT(®) Autoinjector: A Prospective Observational Cohort Study
por: Köhler, Wolfgang, et al.
Publicado: (2021)

Real-World Assessment of Interferon-β-1b and Interferon-β-1a Adherence Before and After the Introduction of the BETACONNECT(®) Autoinjector: A Retrospective Cohort Study
por: Butler, Oisín, et al.
Publicado: (2021)

A Prospective, Observational, Multicenter Study Assessing Adherence to Interferon Beta-1b Therapy and Patient Satisfaction Using the BETACONNECT Auto-Injector
por: Farej, Ryan, et al.
Publicado: (2022)

Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study
por: Kleiter, Ingo, et al.
Publicado: (2017)

BetaEval Global: Prospective, Multinational, Observational Cohort Study of Patients Using BETACONNECT(®)
por: Patti, Francesco, et al.
Publicado: (2020)

Autoinjectors for administration of interferon beta-1b in multiple sclerosis: patient preferences and the ExtaviPro™ 30G and Betacomfort(®) devices
por: Thakur, Kunal, et al.
Publicado: (2013)

Patient and nurse preference for Sensoready autoinjector pen versus other autoinjectors in multiple sclerosis: results from a pilot multicenter survey
por: Ross, Amy Perrin, et al.
Publicado: (2023)

Evolution of the RebiSmart(®) Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis
por: Lin, Yu-Ting, et al.
Publicado: (2023)

The pharmacokinetics of epinephrine/adrenaline autoinjectors
por: Dreborg, Sten, et al.
Publicado: (2021)

Leveraging Dissolution by Autoinjector Designs
por: Spangardt, Christoph, et al.
Publicado: (2022)

Comparative evaluation of patients’ and physicians’ satisfaction with interferon beta-1b therapy
por: Zettl, Uwe Klaus, et al.
Publicado: (2016)

Accidental Digital Ischemia by an Epinephrine Autoinjector
por: Nayaz, Mohamed, et al.
Publicado: (2023)

Patient Evaluation of Satisfaction and Outcomes with an Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus
por: Dashiell-Aje, Ebony, et al.
Publicado: (2017)

Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart(®) Injector: Results of the Prospective Cohort Study REBIFLECT
por: Rieckmann, Peter, et al.
Publicado: (2022)

Patient satisfaction and healthcare services in specialized multiple sclerosis centres in Germany
por: Becker, Veit, et al.
Publicado: (2018)

Adherence with epinephrine autoinjector prescriptions in primary care
por: Abrams, Elissa M., et al.
Publicado: (2017)

Development of an advanced injection time model for an autoinjector
por: Thueer, Thomas, et al.
Publicado: (2018)

Adherence to adrenaline autoinjector prescriptions in patients with anaphylaxis
por: Parke, Louise, et al.
Publicado: (2019)

Who Needs Epinephrine? Anaphylaxis, Autoinjectors, and Parachutes
por: Dribin, Timothy E., et al.
Publicado: (2023)

Health-Related Quality of Life and the Relationship to Treatment Satisfaction in Patients with Multiple Sclerosis: Insights from a Large Observational Study
por: Schriefer, Dirk, et al.
Publicado: (2020)

B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis
por: Tacke, Sabine, et al.
Publicado: (2021)

Comparison of drug delivery with autoinjector versus manual prefilled syringe and between three different autoinjector devices administered in pig thigh
por: Hill, Robert L, et al.
Publicado: (2016)

Bioequivalence evaluation of epinephrine autoinjectors with attention to rapid delivery
por: Sclar, David Alexander
Publicado: (2013)

Autoinjectors Preferred for Intramuscular Epinephrine in Anaphylaxis and Allergic Reactions
por: Campbell, Ronna L., et al.
Publicado: (2016)

Accidental self-administration of an epinephrine autoinjector by a toddler
por: Edgerley, Sarah, et al.
Publicado: (2021)

Are adrenaline autoinjectors fit for purpose? A pilot study of the mechanical and injection performance characteristics of a cartridge-versus a syringe-based autoinjector
por: Schwirtz, Andreas, et al.
Publicado: (2010)

Autoinjector – A smart device for emergency cum personal therapy
por: Roy, Anitha, et al.
Publicado: (2021)

CSACI position statement: transition recommendations on existing epinephrine autoinjectors
por: Li, Lucy Dong Xuan, et al.
Publicado: (2021)

Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe
por: Cohen, Yehuda Z., et al.
Publicado: (2022)

Generic substitution of epinephrine autoinjectors: Patient and caregiver perceptions and attitudes
por: Ray, Sarah E., et al.
Publicado: (2023)

Interferon beta-1b for COVID-19
por: Shalhoub, Sarah
Publicado: (2020)

Two studies in one: A propensity-score-matched comparison of fingolimod versus interferons and glatiramer acetate using real-world data from the independent German studies, PANGAEA and PEARL
por: Alsop, Jonathan, et al.
Publicado: (2017)

Patient Reported Ease-of-Use with a Disposable Autoinjector in Individuals with Migraine
por: Mead, Jennifer, et al.
Publicado: (2020)

Factors contributing to underuse of epinephrine autoinjectors in pediatric patients with food allergy
por: Glassberg, Brittany, et al.
Publicado: (2021)

Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world
por: Ziemssen, Tjalf, et al.
Publicado: (2017)

The Investigation of the Cardiovascular and Sudomotor Autonomic Nervous System—A Review
por: Ziemssen, Tjalf, et al.
Publicado: (2019)

Why Cognitive–Cognitive Dual-Task Testing Assessment Should Be Implemented in Studies on Multiple Sclerosis and in Regular Clinical Practice
por: Beste, Christian, et al.
Publicado: (2020)

Digital Innovation in Multiple Sclerosis Management
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q4sa7c62si449jdcvd6383g74g